Article (Scientific journals)
Efficacy of chondroitin sulfate in patients with knee osteoarthritis: a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials.
Honvo, Germain; Bruyère, Olivier; Geerinck, Anton et al.
2019In Advances in Therapy, 36 (5), p. 1085-99
Peer Reviewed verified by ORBi
 

Files


Full Text
Efficacy Of Chondroitin Sulfate in Patients with Knee Osteoarthritis....pdf
Publisher postprint (1 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
chondroitin sulfate; functional status; meta-analysis; osteoarthritis; pain; rheumatology
Abstract :
[en] Introduction: There are some controversies about treatment modalities in osteoarthritis (OA), including chondroitin sulfate (CS). The objective of this study was to determine whether CS is effective at alleviating pain and improving function in patients with knee OA and to identify the factors that explain inconsistencies in clinical trial results. Methods: We conducted a systematic review of randomized, placebo-controlled trials, searching the databases Medline, Cochrane central register for controlled trials and Scopus. Random effects meta-analysis was then performed, using tau2 and I2 statistics to assess heterogeneity. The pain and Lequesne index (LI) scores were expressed as standardized mean differences (SMDs), with a 95% confidence interval (CI). Heterogeneity was explored by stratifying the analyses according to pre-specified study-level characteristics and assessing the sources of funnel plot asymmetry. Results: The inclusion criteria yielded 18 trials. Overall, CS significantly but inconsistently reduced pain (SMD: - 0.63; 95% CI: - 0.91, - 0.35; I2 = 94%) and improved function (SMD: - 0.82; 95% CI: - 1.31, - 0.33; I2 = 95%). When limiting the analysis to studies with a low risk of bias, the pharmaceutical grade CS of IBSA origin showed a greater reduction in pain (SMD: - 0.25; 95% CI: - 0.34, - 0.16; I2 = 75%) and function (SMD: - 0.33; 95% CI: - 0.47, - 0.20; I2 = 53%, p = 0.07) compared with the other preparations (SMDPain: - 0.08; 95% CI: - 0.19, ? 0.02; I2 = 20%; SMDFunction: - 0.18; 95% CI: - 0.36, ?0.01; I2 = 0%). Assessing funnel plot asymmetry in the studies with a low risk of bias, we found strong correlations between the treatment effects and study size (pain: rS = 0.93; LI: rS = 0.86; p\0.05). Ultimately, there was no residual heterogeneity in the CS effects when the smallest studies were removed from the analyses. Conclusion: This new meta-analysis suggests that CS provides a moderate benefit for pain and has a large effect on function in knee OA, however with large inconsistency. The risks of bias, brand and study size were the factors explaining heterogeneity among the clinical trial results.
Disciplines :
General & internal medicine
Author, co-author :
Honvo, Germain  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie clinique
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Geerinck, Anton ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Veronese, N.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Efficacy of chondroitin sulfate in patients with knee osteoarthritis: a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials.
Publication date :
2019
Journal title :
Advances in Therapy
ISSN :
0741-238X
eISSN :
1865-8652
Publisher :
Springer, New York, United States - New York
Volume :
36
Issue :
5
Pages :
1085-99
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 28 March 2019

Statistics


Number of views
94 (26 by ULiège)
Number of downloads
7 (7 by ULiège)

Scopus citations®
 
44
Scopus citations®
without self-citations
38
OpenCitations
 
37

Bibliography


Similar publications



Contact ORBi